Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
2 "Seong Gyu Hwang"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function
Yeonjung Ha, Daejung Kim, Seungbong Han, Young Eun Chon, Yun Bin Lee, Mi Na Kim, Joo Ho Lee, Hana Park, Kyu Sung Rim, Seong Gyu Hwang
Cancer Res Treat. 2018;50(3):843-851.   Published online September 4, 2017
DOI: https://doi.org/10.4143/crt.2017.232
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study was to demonstrate the prognostic significance of changes in body composition in patients with newly diagnosed hepatocellular carcinoma (HCC).
Materials and Methods
Patients (n=178) newly diagnosed with HCC participated in the study between 2007 and 2012. Areas of skeletal muscle and abdominal fat were directly measured using a three-dimensional workstation. Cox proportional-hazards modes were used to estimate the effect of baseline variables on overall survival. The inverse probability of treatmentweighting (IPTW) method was used to minimize confounding bias.
Results
Cutoff values for sarcopenia, obtained from receiver-operating characteristic curves, were defined as skeletal muscle index at the third lumbar vertebra of ≤ 45.8 cm/m2 for males and ≤ 43.0 cm/m2 for females. Sarcopenia patients were older, more likely to be female, and had lower body mass index. Univariable analysis showed that the presence of sarcopenia and visceral to subcutaneous fat area ratio (VSR) were significantly associatedwith prognosis. The multivariable analyses revealed that VSR was predictive of overall survival. However, in the multivariable Cox model adjusted by IPTW, sarcopenia, not VSR, were associated with overall survival.
Conclusion
The presence of sarcopenia at HCC diagnosis is independently associated with survival.

Citations

Citations to this article as recorded by  
  • The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease
    Mohammed Eslam, Jian-Gao Fan, Ming-Lung Yu, Vincent Wai-Sun Wong, Ian Homer Cua, Chun-Jen Liu, Tawesak Tanwandee, Rino Gani, Wai-Kay Seto, Shahinul Alam, Dan Yock Young, Saeed Hamid, Ming-Hua Zheng, Takumi Kawaguchi, Wah-Kheong Chan, Diana Payawal, Soek-S
    Hepatology International.2025; 19(2): 261.     CrossRef
  • Clinical Significance and Therapeutic Approach Concerning Various Abdominal Adipose Tissue Irregularities in End‐Stage Liver Disease
    Qing Liu, Junling Liu, Chao Sun
    Obesity Reviews.2025;[Epub]     CrossRef
  • Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma
    Mei-Yun Wu, Cheng-Hsi Yeh, Chien-Chang Liao, Chao-Long Chen, Chih-Chi Wang, Chih-Che Lin, Wan- Ching Chang, Yu-Fan Cheng, Hsin-You Ou
    Transplantation Proceedings.2024; 56(3): 573.     CrossRef
  • Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection
    Thanatchawan Polvieng, Sermsak Hongjinda, Anuparp Thienhiran, Pipit Burasakarn, Pusit Fuengfoo
    The American Surgeon™.2024; 90(6): 1447.     CrossRef
  • Hepatocellular carcinoma and musculoskeletal system: A narrative literature review
    Jelena Jadzic, Danijela Djonic
    World Journal of Gastroenterology.2024; 30(15): 2109.     CrossRef
  • Apolipoprotein A-1 downregulation promotes basal-like breast cancer cell proliferation and migration associated with DNA methylation
    Cong Wang, Shiliang Chen, Ranran Zhang, Mengqing Chen, Xiaoxiao Yang, Yibo He, Zuifei Shangguan, Qifen Mao, Zhezhong Zhang, Sunke Ying
    Oncology Letters.2024;[Epub]     CrossRef
  • Association between visceral obesity and tumor recurrence in hepatocellular carcinoma recipients undergoing liver transplantation
    Ji-Hoon Sim, Kyung-Won Kim, YouSun Ko, Young-Jin Moon, Hye-Mee Kwon, In-Gu Jun, Sung-Hoon Kim, Kyoung-Sun Kim, Jun-Gol Song, Gyu-Sam Hwang
    International Journal of Obesity.2023; 47(12): 1214.     CrossRef
  • Association between sarcopenia and clinical outcomes in patients with hepatocellular carcinoma: an updated meta-analysis
    Yusheng Guo, Yanqiao Ren, Licheng Zhu, Lian Yang, Chuansheng Zheng
    Scientific Reports.2023;[Epub]     CrossRef
  • Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives
    Riccardo Casciola, Laura Leoni, Biagio Cuffari, Maddalena Pecchini, Renata Menozzi, Antonio Colecchia, Federico Ravaioli
    Nutrients.2023; 15(4): 863.     CrossRef
  • Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
    Anne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, Johanne Poisson, Maxime Frelaut, Coline Montégut, Soraya Mebarki, Romain Geiss, Zoé ap Thomas, Aurélien Noret, Monica Pierro, Capucine Baldini, Elena Paillaud, Frédéric Pamoukdjian
    Nutrients.2023; 15(5): 1193.     CrossRef
  • Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
    Alexey Surov, Maximilian Thormann, Mattes Hinnerichs, Max Seidensticker, Ricarda Seidensticker, Osman Öcal, Kerstin Schütte, Christoph J. Zech, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Chris Verslype, Bernhard Gebauer, Christian Sengel, Iren
    Hepatology Communications.2023;[Epub]     CrossRef
  • Prevalence of sarcopenia among patients with hepatocellular carcinoma: A systematic review and meta‑analysis
    Jiye Liu, Hanyong Luo, Letian Huang, Jiahe Wang
    Oncology Letters.2023;[Epub]     CrossRef
  • Adipose distribution patterns as prognostic factors in patients with HCC: A systematic review and meta-analysis
    Shuo Shi, Haiyan Yi, Yi Zheng, Yuxuan Zhao, Dexin Yu
    European Journal of Radiology.2023; 167: 111025.     CrossRef
  • Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis
    Xuanmei Li, Xue Huang, Lifu Lei, Shiwen Tong
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • A rapid, non-invasive, clinical surveillance for CachExia, sarcopenia, portal hypertension, and hepatocellular carcinoma in end-stage liver disease: the ACCESS-ESLD study protocol
    Patrik Nasr, Mikael Forsgren, Wile Balkhed, Cecilia Jönsson, Nils Dahlström, Christian Simonsson, Shan Cai, Anna Cederborg, Martin Henriksson, Henrik Stjernman, Martin Rejler, Daniel Sjögren, Gunnar Cedersund, Wolf Bartholomä, Ingvar Rydén, Peter Lundberg
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Sarcopenia as a prognostic indicator of liver cirrhosis
    Sung‐Eun Kim, Dong Joon Kim
    Journal of Cachexia, Sarcopenia and Muscle.2022; 13(1): 8.     CrossRef
  • Comparison of frailty metrics and the Charlson Comorbidity Index for predicting adverse outcomes in patients undergoing surgery for spine metastases
    Andrew M. Hersh, Zach Pennington, Bethany Hung, Jaimin Patel, Earl Goldsborough, Andrew Schilling, James Feghali, Albert Antar, Siddhartha Srivastava, David Botros, Aladine A. Elsamadicy, Sheng-Fu Larry Lo, Daniel M. Sciubba
    Journal of Neurosurgery: Spine.2022; 36(5): 849.     CrossRef
  • Sarcopenia of Cirrhosis and the Therapeutic Potential of Transjugular Intrahepatic Portosystemic Shunt Creation
    Barry Schlansky, Khashayar Farsad
    Digestive Disease Interventions.2022; 06(02): 148.     CrossRef
  • Sarcopenia in hepatocellular carcinoma: Current knowledge and future directions
    Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Saurabh Chandan, Benjamin Tharian, Ragesh Babu Thandassery
    World Journal of Gastroenterology.2022; 28(4): 432.     CrossRef
  • The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
    Yasser Fouad, Gamal Esmat, Reda Elwakil, Serag Zakaria, Ayman Yosry, Imam Waked, Maissa El-Razky, Wahid Doss, Magdy El-Serafy, Ebraheem Mostafa, Mahmood Anees, Mohamed A. Sakr, Nadia AbdelAty, Ashraf Omar, Samy Zaki, Amgad Al-zahaby, Hamdy Mahfouz, Maysaa
    Saudi Journal of Gastroenterology.2022; 28(1): 3.     CrossRef
  • Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis
    Christine March, Jazan Omari, Maximilian Thormann, Maciej Pech, Andreas Wienke, Alexey Surov
    Clinical Nutrition ESPEN.2022; 49: 103.     CrossRef
  • Adiposity and cancer survival: a systematic review and meta-analysis
    En Cheng, Jocelyn Kirley, Elizabeth M. Cespedes Feliciano, Bette J. Caan
    Cancer Causes & Control.2022; 33(10): 1219.     CrossRef
  • Preoperative computed tomography-determined sarcopenia is a reliable prognostic factor in patients with gastric cancer after radical gastrectomy: A sex-specific analysis
    Ting Liu, Xiaoping Yi, Jie Ge, Jinwei Zhang, Fengbo Tan, Kun Song, Heli Liu, Mimi Tang
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • The psoas muscle depletion index is related to the degree of cirrhosis and skeletal muscle loss in patients with end-stage liver disease
    J.C. Hou, Y.M. Zhang, Z Qiang, L.Y. Zhu, H Zheng, Z.Y. Shen
    Acta Gastro Enterologica Belgica.2022; 85(3): 453.     CrossRef
  • Imaging based body composition profiling and outcomes after oncologic liver surgery
    Lorenzo Bernardi, Raffaello Roesel, Filippo Vagelli, Pietro Majno-Hurst, Alessandra Cristaudi
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis
    Chuan Jiang, Yanyan Wang, Wei Fu, Guozhuan Zhang, Xiaoshan Feng, Xing Wang, Fang Wang, Le Zhang, Yang Deng
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • MRI-Derived Sarcopenia Associated with Increased Mortality Following Yttrium-90 Radioembolization of Hepatocellular Carcinoma
    Phillip L. Guichet, Bedros Taslakian, Chenyang Zhan, Eric Aaltonen, Sean Farquharson, Ryan Hickey, Cash J. Horn, Jonathan S. Gross
    CardioVascular and Interventional Radiology.2021; 44(10): 1561.     CrossRef
  • The prevalence and the impact of sarcopenia in digestive cancers. A systematic review
    Carmen Haiducu, Adrian Buzea, Liliana Elena Mirea, Gheorghe Andrei Dan
    Romanian Journal of Internal Medicine.2021; 59(4): 328.     CrossRef
  • Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study
    B. J. Pielkenrood, P. R. van Urk, J. M. van der Velden, N. Kasperts, J. J. C. Verhoeff, G. H. Bol, H. M. Verkooijen, J. J. Verlaan
    Acta Oncologica.2020; 59(3): 291.     CrossRef
  • Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy
    Maryam Ebadi, Carlos Moctezuma-Velazquez, Judith Meza-Junco, Vickie E. Baracos, Abha R. DunichandHoedl, Sunita Ghosh, Philippe Sarlieve, Richard J. Owen, Norman Kneteman, Aldo J. Montano-Loza
    Cancers.2020; 12(2): 356.     CrossRef
  • Review article: prognostic significance of body composition abnormalities in patients with cirrhosis
    Maryam Ebadi, Rahima A. Bhanji, Puneeta Tandon, Vera Mazurak, Vickie E. Baracos, Aldo J. Montano‐Loza
    Alimentary Pharmacology & Therapeutics.2020; 52(4): 600.     CrossRef
  • The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
    Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Paya
    Hepatology International.2020; 14(6): 889.     CrossRef
  • Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
    Sooyeon Oh, Jooho Lee
    Clinical and Molecular Hepatology.2020; 26(4): 476.     CrossRef
  • The role of sarcopenia in patients with intrahepatic cholangiocarcinoma: Prognostic marker or hyped parameter?
    Felix Hahn, Lukas Müller, Fabian Stöhr, Aline Mähringer‐Kunz, Sebastian Schotten, Christoph Düber, Fabian Bartsch, Hauke Lang, Peter R Galle, Arndt Weinmann, Roman Kloeckner
    Liver International.2019; 39(7): 1307.     CrossRef
  • Safety and Prognosis of Transarterial Chemoembolization for Octogenarians with Hepatocellular Carcinoma
    Hua-Ming Cheng, Toshihiro Tanaka, Hideyuki Nishiofuku, Yuto Chanoki, Katsutoshi Horiuchi, Tetsuya Masada, Shota Tatsumoto, Takeshi Matsumoto, Nagaaki Marugami, Kimihiko Kichikawa
    CardioVascular and Interventional Radiology.2019; 42(10): 1413.     CrossRef
  • Visceral Fat Volume From Standard Preoperative CT is an Independent Predictor of Short-term Survival in Patients Undergoing Surgery for Metastatic Spine Disease
    Zach Pennington, Bart Pielkenrood, A. Karim Ahmed, C. Rory Goodwin, Jorrit-Jan Verlaan, Daniel M. Sciubba
    Clinical Spine Surgery: A Spine Publication.2019; 32(6): E303.     CrossRef
  • Sarcopenia in cirrhosis: from pathogenesis to interventions
    Maryam Ebadi, Rahima A. Bhanji, Vera C. Mazurak, Aldo J. Montano-Loza
    Journal of Gastroenterology.2019; 54(10): 845.     CrossRef
  • “Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study”
    Yan Mardian, Yoshihiko Yano, Neneng Ratnasari, Lina Choridah, Widya Wasityastuti, Nurhuda Hendra Setyawan, Yoshitake Hayashi
    BMC Gastroenterology.2019;[Epub]     CrossRef
  • Controversies in Diagnosing Sarcopenia in Cirrhosis—Moving from Research to Clinical Practice
    Marie Sinclair
    Nutrients.2019; 11(10): 2454.     CrossRef
  • Sarcopenia in cirrhosis: a systematic review
    Ovidiu Paul Calapod, Andreea Maria Marin, Laura Carina Tribus, Carmen Fierbinţeanu-Braticevici
    Romanian Journal of Orthopaedic Surgery and Traumatology.2019; 2(2): 125.     CrossRef
  • The Adverse Impact of Sarcopenia and Visceral Fat Deposition on the Course of Hepatocellular Carcinoma and the Role of Nutritional Interventions
    Adam McCulloch, Hardip Malhi, Amritpal Dhaliwal, Sheldon Cooper, Tahir Shah
    European Medical Journal.2018; : 126.     CrossRef
  • 10,207 View
  • 352 Download
  • 46 Web of Science
  • 41 Crossref
Close layer
담도계 및 췌장암의 악성 담도폐색에 있어서 새로운 막부착성 팽창성 금속제 담도배액관 ( Covered Modified - Giantruco Biliary Stent ) 의 개발 및 임상성적
Chan Sup Shim, Young Deok Cho, hyung Keun Bon, Jin Oh Kim, Joo Young Cho, Yun Soo Kim, Joon Seong Lee, Moon Sung Lee, Seong Gyu Hwang, Kyung Min Shin
J Korean Cancer Assoc. 1996;28(2):236-247.
AbstractAbstract PDF
Background
The biliary stents in current use have a tendency to be blocked. In order to maintain long-term patency of stent a larger diameter of biliary stent is needed and the expandable metal stents(EMS) have been developed. But tumor ingrowth was frequently observed in uncovered self-EMS. To overcome the limitations of uncovered self-EMSs, we developed self-EMS covered with polyurethane or polytetrafluoroethylene(PTFE) which was used as artificial vessel. This stent would have more advantages than uncovered self- EMS. Aim: To evaluate the successfulness and the effectiveness of new membrane covered self-EMS(covered modified-Gianturco biliary stent) with polyurethane or PTFE, we studied in patients with malignant biliary obstruction due to biliopancreatic carcinoma. Methods: We developed self-EMS covered with polyurethane or PTFE, and applied covered self-EMS through endoscopic transpapillary or percutaneous transhepatic route in l8 patients of malignant biliary obstruction and 2 benign stricture. We followed-up the patients monthiy with ultrasonography, clinical symptoms and liver function test. There were 13 men and 7 women. The mean age in inrolled patients was 65.6¡¾7.9 year. 10 had CBD cancer, 7 pancreatic head cancer, 1 ampulla of Vater cancer, and 2 benign intrahepatic bile duct stricture. Results: The success rate of covered self-EMS insertion through peroral transpapillary route was 84.6%(11/13) on first trial. In 2 patients with malignant biliary obstruction we couldn't insert covered self-EMS because of technical problems in introducing system, but sucessfully inserted on second trial. And through the Percutaneous transhepatic route, we could also sucessfully applied covered self-EMS in all patients(7/7). There were no complications associated to the procedure of stent implantation. In one case the stent was dislodged spontaneously after 1.3 month, and one patient died after 1 month due to pulmonary metastasis. There was no evidence of biliary reobstruction during follow-up period d[median follow-up 6.75(l.312) months in PTFE patients(4) and 2(l 10) months in polyurethane patients(16)]. Conclusion: We expect that new membrane covered self-EMS has long-term patency and adequacy of biliary drainage, but we cannot completely evaluate the disadvantage of this stent until now due to short-term follow up.
  • 2,512 View
  • 15 Download
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP